Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Becton Dickinson and : BD to Present at Jefferies 2019 London Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/14/2019 | 04:16pm EST

FRANKLIN LAKES, N.J., Nov. 14, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 6:20 a.m. ET.

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, November 28, 2019. 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

Contact: 
Kristen Cardillo, Communications – 201-847-5657 
Monique N. Dolecki, Investor Relations – 201-847-5378

 

Cision
View original content:http://www.prnewswire.com/news-releases/bd-to-present-at-jefferies-2019-london-healthcare-conference-300958784.html

SOURCE BD (Becton, Dickinson and Company)


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON, DICKINSON AND COMP
11/27BECTON DICKINSON AND : & CO Management's Discussion and Analysis of Financial Co..
AQ
11/27BECTON, DICKINSON AND COMPANY : Report
CO
11/22BECTON DICKINSON AND : BD to Present at Evercore ISI 2nd Annual HealthCONx Confe..
PR
11/21BECTON DICKINSON AND : BD Launches Enhanced Antimicrobial Stewardship Analytics ..
PU
11/15BECTON DICKINSON AND : BD Recommends Stockholders Reject Mini-Tender Offer by TR..
PR
11/14BECTON DICKINSON AND : BD to Present at Jefferies 2019 London Healthcare Confere..
PR
11/13BECTON, DICKINSON AND COMPANY : Report
CO
11/12BECTON DICKINSON AND : BD Submits Pre-Market Approval Supplement to FDA for BD O..
PR
11/05GLOBAL MARKETS LIVE : ArcelorMittal, Adecco, Pandora, Samsung…
11/05BECTON DICKINSON AND : Swung to Profit in 4Q
DJ
More news